Exercise of Share Options by Director
Eco Animal Health Group plc announced that Chief Financial Officer Christopher Wilks exercised 4,309 nominal cost share options, which were satisfied by transferring existing ordinary shares from the Employee Benefit Trust, resulting in no new shares being issued. Following this transaction, Mr. Wilks' beneficial shareholding is 178,186 ordinary shares, representing approximately 0.26% of the issued share capital, while the total number of ordinary shares with voting rights remains at 67,759,671.
Select text to share a quote on X · sign in to keep highlights & notes in your EAH notes
ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces that Christopher Wilks, Chief Financial Officer, has exercised 4,309 nominal cost share options granted under the Company's Deferred Bonus Share Options scheme (the "Scheme"). These share options were granted on 12 December 2022 as a deferral of one-third of Mr Wilks' bonus relating to the year ended 31 March 2022.
The exercise has been fully satisfied through the transfer of existing ordinary shares held by the ECO Animal Health Group Employee Benefit Trust ("EBT"). No new ordinary shares have been issued in connection with this transaction.
As a result of this transaction, Mr. Wilks' total beneficial shareholding in the Company is now 178,186 ordinary shares, representing approximately 0.26% of the Company's issued share capital ("ISC").
Therefore, the total number of ordinary shares with voting rights in the Company remains at 67,759,671. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Group under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
The notifications below, provided in accordance with the requirements of the UK Market Abuse Regulation, provide further details
| a. | Name | Christopher Wilks |
| 2. | Reason for the notification | |
| a. | Position/status | Chief Financial Officer |
| b. | Initial notification /Amendment | Initial notification |
| a. | Name | Eco Animal Health Group Plc |
| b. | LEI | 2138009XN9DJ3YP7OB55 |
| a. | Description of the Financial instrument, type of instrument Identification code | Options over ordinary shares of 5p each. GB0032036807 |
| b. | Nature of the transaction | 1. Nominal cost share awards under the Company's Deferred Bonus Share Options ("DBS"). |
| c. | Price(s) and volume(s) | Price(s) Volume(s) 2. DBS 5p 4,309 |
| d. | Aggregated information Aggregated volume Price | n/a |
| f. | Place of the transaction | Off Market |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.